Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. [electronic resource]
Producer: 20060719Description: 209-19 p. digitalISSN:- 0006-8993
- Adrenergic Agents -- toxicity
- Analysis of Variance
- Animals
- Autoradiography -- methods
- Brain -- drug effects
- Brain Chemistry -- drug effects
- Chromatography, High Pressure Liquid -- methods
- Disease Models, Animal
- Dopamine -- metabolism
- Dose-Response Relationship, Drug
- Drug Interactions
- Electrochemistry -- methods
- Gene Expression -- drug effects
- Glutamic Acid -- metabolism
- In Situ Hybridization -- methods
- Injections, Intraventricular -- methods
- Male
- Motor Activity -- drug effects
- Oxidopamine -- toxicity
- Parkinson Disease -- drug therapy
- Piperidines -- therapeutic use
- Protein Binding -- drug effects
- Pyrazoles -- therapeutic use
- RNA, Messenger -- metabolism
- Rats
- Rats, Sprague-Dawley
- Reaction Time -- drug effects
- Receptor, Cannabinoid, CB1 -- antagonists & inhibitors
- Rimonabant
- Rotarod Performance Test -- methods
- Superoxide Dismutase -- genetics
- Superoxide Dismutase-1
- Tyrosine 3-Monooxygenase -- genetics
- gamma-Aminobutyric Acid -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.